Jeff Yass’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Jeff Yass's NRIX Position: Q3 2026 in Review
Jeff Yass increased its Nurix Therapeutics (NRIX) stake by 25% in Q3 2026, buying an estimated $239K and bringing the position to 47,648 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #7629.
Jeff Yass first reported a position in NRIX in Q1 2021 and has held it in 23 quarters since. The position peaked at $1.77M in Q1 2021. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Jeff Yass held 47,648 shares of Nurix Therapeutics worth $1.13M as of Q3 2026.
- Jeff Yass bought 9,568 Nurix Therapeutics shares in Q3 2026, an estimated $239K.
- Nurix Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7629 holding.
- Jeff Yass first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 23 quarters since.
- Jeff Yass's Nurix Therapeutics position peaked at $1.77M in Q1 2021.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.